WaveMan
WaveMan · SEC 13F
Darwin Global Management, Ltd. 13F holdings
> Search tickers & screens ⌘K
LIVE

Darwin Global Management, Ltd. 13F holdings

Darwin Global Management, Ltd. reported 5 positions with a total reported value of $3.8B as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: RVMD REVOLUTION MEDICINES INC (54.5%), INSM INSMED INC (17.9%), BLTE BELITE BIO INC (12.1%), ABVX ABIVAX SA (9.3%), ROIV ROIVANT SCIENCES LTD (6.2%). Against 2026-03-31 it opened 0 new positions and exited 1. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.

Email me when Darwin Global Management, Ltd. files its 13F

A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.

Top holdings

5 largest of 5 positions · reported value as of 2026-06-30
HoldingSharesReported value% of portfolio
RVMD REVOLUTION MEDICINES INC10,629,822$2.0B54.5%
INSM INSMED INC6,431,163$673.6M17.9%
BLTE BELITE BIO INC3,077,219$456.6M12.1%
ABVX ABIVAX SA3,621,583$348.2M9.3%
ROIV ROIVANT SCIENCES LTD6,747,300$234.3M6.2%
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES

New positions this quarter

Held at 2026-06-30, not at 2026-03-31 · 0 in all · reported value as of 2026-06-30

No new positions.

Sold out

Held at 2026-03-31, gone by 2026-06-30 · 1 in all · reported value as of 2026-03-31
HoldingShares 2026-03-31Reported value% of portfolio then
DNTH DIANTHUS THERAPEUTICS INC17,357$1.5M<0.1%

Biggest increases and decreases

Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30

Increases

HoldingShares 2026-03-31Shares 2026-06-30ChangeReported value
RVMD REVOLUTION MEDICINES INC2,211,01810,629,822+380.8%$2.0B
ABVX ABIVAX SA3,468,6573,621,583+4.4%$348.2M
BLTE BELITE BIO INC3,057,4123,077,219+0.6%$456.6M

Decreases

HoldingShares 2026-03-31Shares 2026-06-30ChangeReported value
INSM INSMED INC16,805,1846,431,163-61.7%$673.6M
ROIV ROIVANT SCIENCES LTD6,797,3006,747,300-0.7%$234.3M
CIK 1839209 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-27 · For informational purposes only, not investment advice.
Privacy · Terms